Activation of Galpha q-coupled signaling pathways in glomerular podocytes promotes renal injury - PubMed

Affiliations

• PMID: 16267159
• DOI: 10.1681/ASN.2005020167

Comparative Study

Activation of Galpha q-coupled signaling pathways in glomerular podocytes promotes renal injury

Liming Wang et al. J Am Soc Nephrol. 2005 Dec.

Erratum in

• J Am Soc Nephrol. 2013 Dec;24(12):2126

Abstract

The glomerular podocyte plays a key role in maintaining the integrity of the glomerular filtration barrier. This function may be regulated by activation of cell surface G protein-coupled receptors (GPCR). Studies suggest that podocytes express GPCR that are implicated in the pathogenesis of glomerular diseases. Common to these GPCR systems is activation of phospholipase C through the Gq alpha-subunit (Galpha q). For investigating the role of Galpha q-coupled signaling pathways in promoting renal injury in podocytes, a constitutively active Galpha q subunit (Galpha qQ > L) was expressed in glomerular podocytes using the mouse nephrin promoter. Transgenic (TG) mice demonstrated albuminuria as well as a decrease in both kidney mass and nephron number. By light microscopy, a portion of the TG mice had glomerular abnormalities, including focal to diffuse hypercellularity and segmental sclerosis. Consistent with injury-promoting effects of Galpha qQ > L, there was a significant reduction in podocalyxin mRNA as well as nephrin mRNA and protein levels in glomeruli from TG mice compared with non-TG controls. Expression of the transgene also seemed to increase susceptibility to glomerular injury, because treatment with puromycin aminonucleoside enhanced proteinuria in TG mice compared with non-TG littermate controls (4.2 +/- 1.0 [TG] versus 1.6 +/- 0.3 [non-TG] mg/24 h; P = 0.0161). Thus, activation of Galpha q in glomerular podocytes caused alterations in glomerular histomorphology, albuminuria, decreased nephron mass, and reduced glomerular expression of both nephrin and podocalyxin as well as enhanced susceptibility to glomerular damage induced by puromycin aminonucleoside. It is speculated that Galpha q-coupled signaling cascades may be important effector pathways mediating renal injury.

Similar articles

• Galphaq signaling is required for Rho-dependent transcriptional activation of the cyclooxygenase-2 promoter in fibroblasts.

  Slice LW, Han SK, Simon MI. Slice LW, et al. J Cell Physiol. 2003 Feb;194(2):127-38. doi: 10.1002/jcp.10195. J Cell Physiol. 2003. PMID: 12494451

• GIV/girdin links vascular endothelial growth factor signaling to Akt survival signaling in podocytes independent of nephrin.

  Wang H, Misaki T, Taupin V, Eguchi A, Ghosh P, Farquhar MG. Wang H, et al. J Am Soc Nephrol. 2015 Feb;26(2):314-27. doi: 10.1681/ASN.2013090985. Epub 2014 Jul 10. J Am Soc Nephrol. 2015. PMID: 25012178 Free PMC article.

• Gq signaling causes glomerular injury by activating TRPC6.

  Wang L, Jirka G, Rosenberg PB, Buckley AF, Gomez JA, Fields TA, Winn MP, Spurney RF. Wang L, et al. J Clin Invest. 2015 May;125(5):1913-26. doi: 10.1172/JCI76767. Epub 2015 Apr 6. J Clin Invest. 2015. PMID: 25844902 Free PMC article.

• Proteinuria: detection and role in native renal disease progression.

  Gorriz JL, Martinez-Castelao A. Gorriz JL, et al. Transplant Rev (Orlando). 2012 Jan;26(1):3-13. doi: 10.1016/j.trre.2011.10.002. Transplant Rev (Orlando). 2012. PMID: 22137726 Review.

• Targeting signaling pathways in glomerular diseases.

  Henique C, Tharaux PL. Henique C, et al. Curr Opin Nephrol Hypertens. 2012 Jul;21(4):417-27. doi: 10.1097/MNH.0b013e328354a598. Curr Opin Nephrol Hypertens. 2012. PMID: 22660552 Review.

Cited by

• NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.

  Zhang L, Li R, Shi W, Liang X, Liu S, Ye Z, Yu C, Chen Y, Zhang B, Wang W, Lai Y, Ma J, Li Z, Tan X. Zhang L, et al. Br J Pharmacol. 2013 Sep;170(2):426-39. doi: 10.1111/bph.12292. Br J Pharmacol. 2013. PMID: 23826864 Free PMC article.

• Mechanisms of the proteinuria induced by Rho GTPases.

  Wang L, Ellis MJ, Gomez JA, Eisner W, Fennell W, Howell DN, Ruiz P, Fields TA, Spurney RF. Wang L, et al. Kidney Int. 2012 Jun;81(11):1075-85. doi: 10.1038/ki.2011.472. Epub 2012 Jan 25. Kidney Int. 2012. PMID: 22278020 Free PMC article.

• Activation of adenosine 2A receptors preserves structure and function of podocytes.

  Awad AS, Rouse M, Liu L, Vergis AL, Rosin DL, Linden J, Sedor JR, Okusa MD. Awad AS, et al. J Am Soc Nephrol. 2008 Jan;19(1):59-68. doi: 10.1681/ASN.2007030276. Epub 2007 Nov 28. J Am Soc Nephrol. 2008. PMID: 18045850 Free PMC article.

• A maladaptive role for EP4 receptors in podocytes.

  Stitt-Cavanagh EM, Faour WH, Takami K, Carter A, Vanderhyden B, Guan Y, Schneider A, Breyer MD, Kennedy CR. Stitt-Cavanagh EM, et al. J Am Soc Nephrol. 2010 Oct;21(10):1678-90. doi: 10.1681/ASN.2009121234. Epub 2010 Jul 29. J Am Soc Nephrol. 2010. PMID: 20671216 Free PMC article.

• β-Arrestins promote podocyte injury by inhibition of autophagy in diabetic nephropathy.

  Liu J, Li QX, Wang XJ, Zhang C, Duan YQ, Wang ZY, Zhang Y, Yu X, Li NJ, Sun JP, Yi F. Liu J, et al. Cell Death Dis. 2016 Apr 7;7(4):e2183. doi: 10.1038/cddis.2016.89. Cell Death Dis. 2016. PMID: 27054338 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wolters Kluwer

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)

• Miscellaneous

  • NCI CPTAC Assay Portal